Does ACALABRUTINIB Cause Product use issue? 71 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Product use issue have been filed in association with ACALABRUTINIB (CALQUENCE). This represents 0.7% of all adverse event reports for ACALABRUTINIB.
71
Reports of Product use issue with ACALABRUTINIB
0.7%
of all ACALABRUTINIB reports
3
Deaths
20
Hospitalizations
How Dangerous Is Product use issue From ACALABRUTINIB?
Of the 71 reports, 3 (4.2%) resulted in death, 20 (28.2%) required hospitalization.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ACALABRUTINIB. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does ACALABRUTINIB Cause?
Death (1,857)
Fatigue (536)
Headache (534)
Product dose omission issue (349)
Diarrhoea (320)
Fall (289)
Malignant neoplasm progression (285)
Contusion (270)
Dyspnoea (259)
Pneumonia (244)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which ACALABRUTINIB Alternatives Have Lower Product use issue Risk?
ACALABRUTINIB vs ACAMPROSATE
ACALABRUTINIB vs ACARBOSE
ACALABRUTINIB vs ACCUTANE
ACALABRUTINIB vs ACEBUTOLOL
ACALABRUTINIB vs ACECLOFENAC